Prevent the Event: Defining the Risk of Atherothrombosis
The primary care clinician plays a critical role in early diagnosis and detection of atherothrombosis, since the earliest signs and symptoms are often subtle and appear many years before its full-blown manifestation. Both primary and secondary prevention strategies include long term risk factor modification. For either primary or secondary prevention to be effective, provider/patient communication leading to good adherence to medication and lifestyle modifications is absolutely essential.

Upon completion of this interactive case, involving the initial visit of a 56-year-old African American male employed as a truck driver who has been nonadherent with other clinicians’ recommendations in the past, participants should be able to identify traditional and emerging risk factors that may aid in identifying patients at risk and with subclinical cardiovascular disease.

The focus on the first visit is to establish a complete database on CV risk factors—verification, duration, prior treatment(s), and responses. There are two other opportunities to interactively follow this particular patient’s progress.

» Go to this activity

Prevent The Event: Treatment Strategies For the ACS patient
This activity involving the second visit of the same nonadherent patient seen six months ago with risk factors for CAD is important as the patient now presents with probable stable angina. Key decision points include addressing both existing risk factors and current symptoms.

» Go to this activity

Prevent The Event: Complexities of the Patient with ACS
Upon completion of this interactive case involving the same patient’s third visit, following a non ST segment elevation myocardial infarction (NSTEMI) with a drug eluting stent placed, participants should be able to implement current guidelines for oral antiplatelet therapy in patients with all forms of atherothrombosis.

» Go to this activity

ACC/AHA Guideline Recommendations Following Acute Coronary Syndrome: A Key to Their Hearts Educational Activity
In patients with acute coronary syndrome, use of lipid-lowering, antihypertensive, anti-ischemic, and antiplatelet therapies have greatly improved patients' quality of life and have proved very useful in secondary prevention of cardiac events. Long-term use of each of these pharmacotherapies in patients with ACS provides incremental benefit, and in combination, they decrease morbidity and improve overall survival.

Upon completion of this activity, participants should be able to ensure that patients are started on and remain adherent with statin, ß-blocker, inhibitors of the renin-angiotensin-aldosterone axis, aspirin, and thienopyridine therapy in the setting of post-ACS according to ACC/AHA/SCAI guidelines to reduce risk for reinfarction and mortality.

» Go to this activity

You are subscribed to ModernMedicine.com. To unsubscribe, click here

To ensure delivery to your Inbox, please add us to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.